Regeneron Pharmaceuticals | Należności Handlowe



Trade Debtors Zmiana Data
AbbVie USD 12.48B 1.56B 2025-03
Agios Pharmaceuticals USD 4.99M 1.64M 2025-06
Alnylam Pharmaceuticals USD 567.11M 149.08M 2025-06
Amgen USD 8.7B 569M 2025-06
Astellas Pharma JPY 699.5B 53.29B 2025-06
AstraZeneca USD 16.24B 1.42B 2025-06
Biogen USD 2.08B 87.5M 2025-06
BioMarin Pharmaceutical USD 855.85M 116.68M 2025-06
Bristol-Myers Squibb USD 15.1B 515M 2025-06
Eli Lilly USD 17.21B 3.2B 2025-06
Gilead Sciences USD 4.78B 393M 2025-06
GlaxoSmithKline GBP 7.7B 196M 2025-06
Incyte USD 842.89M 19.76M 2025-06
Ionis Pharmaceuticals USD 52.58M 12.87M 2025-06
J&J USD 16.02B 1.18B 2025-03
Kyowa Hakko Kirin JPY 158.71B 22.21B 2025-06
Merck USD 12.72B 1.14B 2025-06
Moderna USD 457M 151M 2025-06
Neurocrine Biosciences USD 595.7M 79.7M 2025-06
Novartis USD 9.18B 451M 2025-06
Novartis USD 7.56B 594M 2024-12
Pfizer USD 16.09B 1.35B 2025-06
Regeneron Pharmaceuticals USD 5.61B 49M 2025-06
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 10.63B 1.82B 2024-12
Sarepta Therapeutics USD 609.6M 114.93M 2025-06
Teva Pharmaceutical Industries USD 3.56B 180M 2025-06
Ultragenyx Pharmaceutical USD 124.46M 25.62M 2025-06
United Therapeutics USD 379.3M 57.3M 2025-06
Vertex Pharmaceuticals USD 1.89B 88.4M 2025-06


Regeneron Pharmaceuticals Należności Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.